MARKET

TCRT

TCRT

Alaunos Therapeutics, Inc
NASDAQ
1.979
-0.071
-3.46%
Opening 14:52 09/29 EDT
OPEN
2.010
PREV CLOSE
2.050
HIGH
2.100
LOW
1.920
VOLUME
1.54M
TURNOVER
1.97M
52 WEEK HIGH
4.010
52 WEEK LOW
0.4053
MARKET CAP
427.85M
P/E (TTM)
-7.8349
1D
5D
1M
3M
1Y
5Y
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Wednesday after closing mostly lower on Tuesday. The S&P 500 index dropped deeper into a bear market after hitting a fresh 2022 low. The S&P 500 is now down 24.3% from its record level in January, while the Dow is now 21.2% below its record high.
Benzinga · 1d ago
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
Gainers
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
Benzinga · 3d ago
Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session
Gainers
Benzinga · 3d ago
TCRT, MYMD and TKAT among mid-day movers
Gainers: LAVA Therapeutics LVTX +90%. AEA-Bridges Impact (<a href="https://seekingalpha.com/symbol/IMPX?utm_medium=referral&utm_source=webull.com" title="AEA-Bridges Impact Corp." target...
Seekingalpha · 3d ago
Cohn Robbins Holdings, Melco Resorts And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Benzinga · 3d ago
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading.
Benzinga · 6d ago
Alaunos “checked all the boxes” with early data for cancer therapy – Cantor
After over a 20% decline in the previous session, clinical-stage biotech Alaunos Therapeutics, Inc. (NASDAQ:<a href="https://seekingalpha.com/symbol/TCRT?utm_medium=referral&utm_source=webull.com" title="Alaunos...
Seekingalpha · 09/22 18:06
More
About TCRT
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is engaged in developing adoptive TCR engineered T-cell therapies (TCR-T), designed to treat multiple solid tumor types in large cancer patient populations. The Company is leveraging its cancer mutation hotspot TCR library and its non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from common tumor-related mutations in key oncogenic genes, including KRAS, TP53 and EGFR. Its TCR library consists of ten TCRs targeting six solid tumor indications, including non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers. Using its human neoantigen T cell Receptor (hunTR) discovery engine, it analyzes thousands of single T cells simultaneously using bioinformatics and next generation sequencing. Its pipeline includes Library TCR-T cell therapy and mbIL-15 TCR-T cell therapy.

Webull offers kinds of Alaunos Therapeutics Inc stock information, including NASDAQ:TCRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCRT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCRT stock methods without spending real money on the virtual paper trading platform.